Please assess the completion status of the following clinical trial:

Trial Title: Interactive Acute Smooth Muscle Effects of Salmeterol and Fluticasone in the Airway

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion Criteria:~1. Males and females, 18 to 65 years of age.~2. FEV1 60-85% of predicted on the screening day. -~Exclusion Criteria:~1. Women of childbearing potential who do not use accepted birth control measures; pregnant and breast feeding women. 2. Cardiovascular disease and/or use of cardiovascular medications 3. Subjects with known beta-adrenergic agonist or glucocorticosteroid intolerance 4. Acute respiratory infection within four weeks prior to the study 5. Use, within two weeks prior to the study, of any anti-asthma medication not mentioned above~-

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- fluticasone/salmeterol (Type: EXPERIMENTAL): participants were treated fluticasone/salmeterol,
- salmeterol (Type: EXPERIMENTAL): participants were treated with salmeterol
- fluticasone (Type: EXPERIMENTAL): participants were treated with fluticasone
- placebo inhalation (Type: PLACEBO_COMPARATOR): participants were treated with placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).